Evidence map›Paper›PMID 26759638›Full record

ArticleBiomicrofluidics2015

A microfluidic platform for size-dependent generation of droplet interface bilayer networks on rails.

P Carreras, Y Elani, R V Law, N J Brooks, J M Seddon, O Ces

Abstract read
In one paragraph

Article in Biomicrofluidics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Reconfigurable droplet networks.Nature communications · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology.Angewandte Chemie (International ed. in English) · 2021
    Review
  7. Interfacing Living and Synthetic Cells as an Emerging Frontier in Synthetic Biology.Angewandte Chemie (Weinheim an der Bergstrasse, Germany) · 2021
    Review
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

P CarrerasDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
Y ElaniDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
R V LawDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
N J BrooksDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
J M SeddonDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.
O CesDepartment of Chemistry and Institute of Chemical Biology , Imperial College London, Exhibition Road, London SW7 2AZ, United Kingdom.

Funding

Biotechnology and Biological Sciences Research Council BB/F013167/1
6 · The paper itself

Abstract

Droplet interface bilayer (DIB) networks are emerging as a cornerstone technology for the bottom up construction of cell-like and tissue-like structures and bio-devices. They are an exciting and versatile model-membrane platform, seeing increasing use in the disciplines of synthetic biology, chemical biology, and membrane biophysics. DIBs are formed when lipid-coated water-in-oil droplets are brought together-oil is excluded from the interface, resulting in a bilayer. Perhaps the greatest feature of the DIB platform is the ability to generate bilayer networks by connecting multiple droplets together, which can in turn be used in applications ranging from tissue mimics, multicellular models, and bio-devices. For such applications, the construction and release of DIB networks of defined size and composition on-demand is crucial. We have developed a droplet-based microfluidic method for the generation of different sized DIB networks (300-1500 pl droplets) on-chip. We do this by employing a droplet-on-rails strategy where droplets are guided down designated paths of a chip with the aid of microfabricated grooves or "rails," and droplets of set sizes are selectively directed to specific rails using auxiliary flows. In this way we can uniquely produce parallel bilayer networks of defined sizes. By trapping several droplets in a rail, extended DIB networks containing up to 20 sequential bilayers could be constructed. The trapped DIB arrays can be composed of different lipid types and can be released on-demand and regenerated within seconds. We show that chemical signals can be propagated across the bio-network by transplanting enzymatic reaction cascades for inter-droplet communication.

Identifiers

PMID26759638
PMCPMC4698115

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.